Stryker Operating Expenses Growth & History (SYK)
Stryker's operating expenses was $11.18B for fiscal 2025.
View full Stryker company overviewStryker annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.18B | $425.0M | +3.95% |
| 2024 | 2024-12-31 | $10.75B | $1.58B | +17.24% |
| 2023 | 2023-12-31 | $9.17B | $433.0M | +4.96% |
| 2022 | 2022-12-31 | $8.74B | $353.0M | +4.21% |
| 2021 | 2021-12-31 | $8.38B | $1.55B | +22.68% |
| 2020 | 2020-12-31 | $6.83B | −$149.0M | −2.13% |
| 2019 | 2019-12-31 | $6.98B | $582.0M | +9.09% |
| 2018 | 2018-12-31 | $6.40B | $518.0M | +8.81% |
| 2017 | 2017-12-31 | $5.88B | $554.0M | +10.40% |
| 2016 | 2016-12-31 | $5.33B | $588.0M | +12.40% |
| 2015 | 2015-12-31 | $4.74B | −$369.0M | −7.22% |
| 2014 | 2014-12-31 | $5.11B | $347.0M | +7.29% |
| 2013 | 2013-12-31 | $4.76B | $628.0M | +15.19% |
| 2012 | 2012-12-31 | $4.13B | $325.0M | +8.53% |
| 2011 | 2011-12-31 | $3.81B | $527.0M | +16.05% |
| 2010 | 2010-12-31 | $3.28B | $338.0M | +11.48% |
| 2009 | 2009-12-31 | $2.94B | −$122.8M | −4.00% |
| 2008 | 2008-12-31 | $3.07B | $239.8M | +8.48% |
| 2007 | 2007-12-31 | $2.83B | — | — |
Stryker quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.84B | $111.0M | +4.07% |
| Q1 2026 | 2026-03-31 | $2.87B | −$33.0M | −1.14% |
| Q4 2025 | 2025-12-31 | $2.82B | −$769.0M | −21.40% |
| Q3 2025 | 2025-09-30 | $2.72B | $285.0M | +11.72% |
| Q2 2025 | 2025-06-30 | $2.73B | $363.0M | +15.35% |
| Q1 2025 | 2025-03-31 | $2.91B | $546.0M | +23.13% |
| Q4 2024 | 2024-12-31 | $3.59B | $1.15B | +46.89% |
| Q3 2024 | 2024-09-30 | $2.43B | $205.0M | +9.21% |
| Q2 2024 | 2024-06-30 | $2.37B | $149.0M | +6.72% |
| Q1 2024 | 2024-03-31 | $2.36B | $80.0M | +3.51% |
| Q4 2023 | 2023-12-31 | $2.45B | $24.0M | +0.99% |
| Q3 2023 | 2023-09-30 | $2.23B | $253.0M | +12.82% |
| Q2 2023 | 2023-06-30 | $2.22B | $162.0M | +7.89% |
| Q1 2023 | 2023-03-31 | $2.28B | −$6.0M | −0.26% |
| Q4 2022 | 2022-12-31 | $2.42B | $196.0M | +8.81% |
| Q3 2022 | 2022-09-30 | $1.97B | −$94.0M | −4.55% |
| Q2 2022 | 2022-06-30 | $2.05B | $14.0M | +0.69% |
| Q1 2022 | 2022-03-31 | $2.29B | $237.0M | +11.56% |
| Q4 2021 | 2021-12-31 | $2.23B | $258.0M | +13.11% |
| Q3 2021 | 2021-09-30 | $2.07B | $466.0M | +29.09% |
| Q2 2021 | 2021-06-30 | $2.04B | $472.0M | +30.10% |
| Q1 2021 | 2021-03-31 | $2.05B | $354.0M | +20.87% |
| Q4 2020 | 2020-12-31 | $1.97B | $209.0M | +11.88% |
| Q3 2020 | 2020-09-30 | $1.60B | −$100.0M | −5.88% |
| Q2 2020 | 2020-06-30 | $1.57B | −$199.0M | −11.26% |
| Q1 2020 | 2020-03-31 | $1.70B | −$59.0M | −3.36% |
| Q4 2019 | 2019-12-31 | $1.76B | $1.0M | +0.06% |
| Q3 2019 | 2019-09-30 | $1.70B | $123.0M | +7.79% |
| Q2 2019 | 2019-06-30 | $1.77B | $249.0M | +16.40% |
| Q1 2019 | 2019-03-31 | $1.75B | $209.0M | +13.52% |
| Q4 2018 | 2018-12-31 | $1.76B | $231.0M | +15.13% |
| Q3 2018 | 2018-09-30 | $1.58B | $120.0M | +8.22% |
| Q2 2018 | 2018-06-30 | $1.52B | $29.0M | +1.95% |
| Q1 2018 | 2018-03-31 | $1.55B | $138.0M | +9.80% |
| Q4 2017 | 2017-12-31 | $1.53B | $102.0M | +7.16% |
| Q3 2017 | 2017-09-30 | $1.46B | $72.0M | +5.19% |
| Q2 2017 | 2017-06-30 | $1.49B | $147.0M | +10.95% |
| Q1 2017 | 2017-03-31 | $1.41B | $233.0M | +19.83% |
| Q4 2016 | 2016-12-31 | $1.43B | $253.0M | +21.59% |
| Q3 2016 | 2016-09-30 | $1.39B | $141.0M | +11.32% |
| Q2 2016 | 2016-06-30 | $1.34B | $166.0M | +14.12% |
| Q1 2016 | 2016-03-31 | $1.18B | $28.0M | +2.44% |
| Q4 2015 | 2015-12-31 | $1.17B | −$79.0M | −6.31% |
| Q3 2015 | 2015-09-30 | $1.25B | $136.0M | +12.25% |
| Q2 2015 | 2015-06-30 | $1.18B | −$175.0M | −12.95% |
| Q1 2015 | 2015-03-31 | $1.15B | −$251.0M | −17.95% |
| Q4 2014 | 2014-12-31 | $1.25B | $90.0M | +7.75% |
| Q3 2014 | 2014-09-30 | $1.11B | −$209.0M | −15.85% |
| Q2 2014 | 2014-06-30 | $1.35B | $159.0M | +13.34% |
| Q1 2014 | 2014-03-31 | $1.40B | $307.0M | +28.14% |
| Q4 2013 | 2013-12-31 | $1.16B | −$62.0M | −5.07% |
| Q3 2013 | 2013-09-30 | $1.32B | $372.0M | +39.28% |
| Q2 2013 | 2013-06-30 | $1.19B | $203.0M | +20.53% |
| Q1 2013 | 2013-03-31 | $1.09B | $115.0M | +11.78% |
| Q4 2012 | 2012-12-31 | $1.22B | $166.0M | +15.70% |
| Q3 2012 | 2012-09-30 | $947.0M | $29.0M | +3.16% |
| Q2 2012 | 2012-06-30 | $989.0M | $57.0M | +6.12% |
| Q1 2012 | 2012-03-31 | $976.0M | $73.0M | +8.08% |
| Q4 2011 | 2011-12-31 | $1.06B | $72.1M | +7.32% |
| Q3 2011 | 2011-09-30 | $918.0M | $162.0M | +21.43% |
| Q2 2011 | 2011-06-30 | $932.0M | $161.2M | +20.91% |
| Q1 2011 | 2011-03-31 | $903.0M | $131.7M | +17.08% |
| Q4 2010 | 2010-12-31 | $984.9M | $257.9M | +35.47% |
| Q3 2010 | 2010-09-30 | $756.0M | −$47.2M | −5.88% |
| Q2 2010 | 2010-06-30 | $770.8M | $62.6M | +8.84% |
| Q1 2010 | 2010-03-31 | $771.3M | $64.7M | +9.16% |
| Q4 2009 | 2009-12-31 | $727.0M | — | — |
| Q3 2009 | 2009-09-30 | $803.2M | $56.0M | +7.49% |
| Q2 2009 | 2009-06-30 | $708.2M | −$70.3M | −9.03% |
| Q1 2009 | 2009-03-31 | $706.6M | — | — |
| Q3 2008 | 2008-09-30 | $747.2M | — | — |
| Q2 2008 | 2008-06-30 | $778.5M | — | — |
Stryker operating expenses trends
Over the last five fiscal years, Stryker's operating expenses increased from $6.83B to $11.18B, a change of $4.34B. The latest reported quarter, Q2 2026, shows $2.84B.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Stryker source filings ↗Community posts
Stryker completes ZuriMED acquisition to broaden its shoulder-repair offering
Stryker ($SYK) completed its acquisition of privately held ZuriMED, adding FiberLocker technology to its sports medicine business. The commercialized product is used to augment rotator cuff repair and is designed to increase the mechanical ...